EP1906936 - FORMULATIONS CONTAINING LOSARTAN AND/OR ITS SALTS [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 28.01.2011 Database last updated on 22.08.2024 | Most recent event Tooltip | 28.01.2011 | Application deemed to be withdrawn | published on 02.03.2011 [2011/09] | Applicant(s) | For all designated states Combino Pharm, S.L. Fructuós Gelabert, 6-8 08970 Saint Joan Despi / ES | [2008/15] | Inventor(s) | 01 /
LLORET PEREZ, Sergio Coroleu, 22, Esc. A, 2 ,1a E-08030 Barcelona / ES | [2008/15] | Representative(s) | Duncan, Garreth Andrew, et al D Young & Co LLP 120 Holborn London EC1N 2DY / GB | [N/P] |
Former [2008/15] | Duncan, Garreth Andrew, et al D Young & Co 120 Holborn London EC1N 2DY / GB | Application number, filing date | 06821014.5 | 17.05.2006 | [2008/15] | WO2006IB03440 | Priority number, date | US20050681961P | 18.05.2005 Original published format: US 681961 P | [2008/15] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | WO2007026261 | Date: | 08.03.2007 | Language: | EN | [2007/10] | Type: | A2 Application without search report | No.: | EP1906936 | Date: | 09.04.2008 | Language: | EN | The application published by WIPO in one of the EPO official languages on 08.03.2007 takes the place of the publication of the European patent application. | [2008/15] | Search report(s) | International search report - published on: | EP | 03.01.2008 | Classification | IPC: | A61K9/20, A61K9/28, A61K31/41, A61K31/4178 | [2008/15] | CPC: |
A61K9/2054 (EP,US);
A61K31/41 (EP,US);
A61K31/4178 (EP,US);
A61K9/2018 (EP,US);
A61K9/2059 (EP,US);
A61K9/2866 (EP,US);
A61P9/12 (EP)
(-)
| Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR [2008/15] | Extension states | AL | Not yet paid | BA | Not yet paid | HR | Not yet paid | MK | Not yet paid | YU | Not yet paid | Title | German: | FORMULIERUNGEN MIT LOSARTAN UND/ODER DESSEN SALZEN | [2008/15] | English: | FORMULATIONS CONTAINING LOSARTAN AND/OR ITS SALTS | [2008/15] | French: | PREPARATIONS CONTENANT DU LOSARTAN ET/OU DES SELS DE CE COMPOSE | [2008/15] | Entry into regional phase | 19.12.2007 | National basic fee paid | 19.12.2007 | Designation fee(s) paid | 19.12.2007 | Examination fee paid | Examination procedure | 19.12.2007 | Examination requested [2008/15] | 28.05.2008 | Despatch of a communication from the examining division (Time limit: M06) | 28.11.2008 | Reply to a communication from the examining division | 29.03.2010 | Communication of intention to grant the patent | 10.08.2010 | Application deemed to be withdrawn, date of legal effect [2011/09] | 27.09.2010 | Despatch of communication that the application is deemed to be withdrawn, reason: fee for grant / fee for printing not paid in time [2011/09] | Request for further processing for: | The application is deemed to be withdrawn due to non-payment of the filing fee | 14.02.2008 | Request for further processing filed | 14.02.2008 | Full payment received (date of receipt of payment) Request granted | 28.02.2008 | Decision despatched | Fees paid | Renewal fee | 18.03.2008 | Renewal fee patent year 03 | 07.05.2009 | Renewal fee patent year 04 | Penalty fee | Additional fee for renewal fee | 31.05.2010 | 05   M06   Not yet paid |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [XI]WO2004017896 (MERCK & CO INC [US], et al) [X] 11 * page 19, lines 14-34 * * page 26, lines 6-18 * [I] 1-10,12,13; | [XI]EP0511767 (MERCK & CO INC [US]) [X] 11,13 * page 3, line 47 - page 4, line 2 * * examples 1,2 * [I] 12; | [X]WO9749392 (MERCK & CO INC [US], et al) [X] 11-13 * pages 9-13 *; | [XI]WO2004066997 (LEK PHARMACEUTICALS [SI], et al) [X] 11,12 * page 29, paragraph 3 * * page 31, paragraphs 2-4 * * pages 44-45; tables 4,5 * * pages 66-68; examples 50,51 * [I] 13; | [PI] - MADAN ET AL, "PHARMACEUTICAL COMPOSITION COMPRISING ATORVASTATIN AND LOSARTAN", IP.COM JOURNAL, IP.COM INC., WEST HENRIETTA, NY, US, (20061214), ISSN 1533-0001, XP013117222 [PI] 1-6,11-13 * pages 9-11; example . * |